MARK BOYACK: Open Payments
NPI 1750323986 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 50 payments from 14 companies in 2025. Trend: 2023 $1,116 · 2024 $1,155 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $189 |
| Amgen Inc. | 10 | $138 |
| Calliditas Therapeutics US Inc. | 4 | $95 |
| ANI Pharmaceuticals, Inc. | 4 | $90 |
| Travere Therapeutics, Inc. | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Baxter Healthcare | 1 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| United Therapeutics Corporation | 1 | $27 |
Products named: Kerendia, TARPEYO, PURIFIED CORTROPHIN GEL, TAVNEOS, KRYSTEXXA, FARXIGA, Hillrom - Vest System Model 105 Home Care, JYNARQUE.
Industry payments across UT — which companies pay providers there.
